1-8 of 8
Christopher D. Gocke
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Artificial Intelligence-Assisted Serial Analysis of Clinical Cancer Genomics Data Identifies Changing Treatment Recommendations and Therapeutic Targets

Catherine G. Fischer, Aparna Pallavajjala, LiQun Jiang, Valsamo Anagnostou, Jessica Tao, Emily Adams, James R. Eshleman, Christopher D. Gocke, Ming-Tseh Lin, Elizabeth A. Platz, Rena R. Xian
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (11): 2361–2372.
https://doi.org/10.1158/1078-0432.CCR-21-4061
Published: 01 June 2022
View article titled, Artificial Intelligence-Assisted Serial Analysis of Clinical Cancer Genomics Data Identifies Changing Treatment Recommendations and Therapeutic Targets
Open the PDF for Artificial Intelligence-Assisted Serial Analysis of Clinical Cancer Genomics Data Identifies Changing Treatment Recommendations and Therapeutic Targets in another window
Includes: Supplementary data
Journal Articles

A Phase I Trial of the VEGF Receptor Tyrosine Kinase Inhibitor Pazopanib in Combination with the MEK Inhibitor Trametinib in Advanced Solid Tumors and Differentiated Thyroid Cancers

Razelle Kurzrock, Douglas W. Ball, Marianna L. Zahurak, Barry D. Nelkin, Vivek Subbiah, Shabina Ahmed, Ashley O'Connor, Enusha Karunsena, Rose M. Parkinson, Justin A. Bishop, Yoonji Ha, Rajni Sharma, Christopher D. Gocke, Ralph Zinner, Michelle A. Rudek, Steven I. Sherman, Nilofer S. Azad
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (18): 5475–5484.
https://doi.org/10.1158/1078-0432.CCR-18-1881
Published: 13 September 2019
View article titled, A Phase I Trial of the VEGF Receptor Tyrosine Kinase Inhibitor Pazopanib in Combination with the MEK Inhibitor Trametinib in Advanced Solid Tumors and Differentiated Thyroid Cancers
Open the PDF for A Phase I Trial of the VEGF Receptor Tyrosine Kinase Inhibitor Pazopanib in Combination with the MEK Inhibitor Trametinib in Advanced Solid Tumors and Differentiated Thyroid Cancers in another window
Includes: Supplementary data
Journal Articles

Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer

Vincent P. Groot, Stacy Mosier, Ammar A. Javed, Jonathan A. Teinor, Georgios Gemenetzis, Ding Ding, Lisa M. Haley, Jun Yu, Richard A. Burkhart, Alina Hasanain, Marija Debeljak, Hirohiko Kamiyama, Amol Narang, Daniel A. Laheru, Lei Zheng, Ming-Tseh Lin, Christopher D. Gocke, Elliot K. Fishman, Ralph H. Hruban, Michael G. Goggins, I. Quintus Molenaar, John L. Cameron, Matthew J. Weiss, Victor E. Velculescu, Jin He, Christopher L. Wolfgang, James R. Eshleman
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (16): 4973–4984.
https://doi.org/10.1158/1078-0432.CCR-19-0197
Published: 15 August 2019
View article titled, Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer
Open the PDF for Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer in another window
Includes: Supplementary data
Journal Articles

Whole-Exome Sequencing of Metaplastic Breast Carcinoma Indicates Monoclonality with Associated Ductal Carcinoma Component

Bracha Erlanger Avigdor, Katie Beierl, Christopher D. Gocke, Daniel J. Zabransky, Karen Cravero, Kelly Kyker-Snowman, Berry Button, David Chu, Sarah Croessmann, Rory L. Cochran, Roisin M. Connolly, Ben H. Park, Sarah J. Wheelan, Ashley Cimino-Mathews
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (16): 4875–4884.
https://doi.org/10.1158/1078-0432.CCR-17-0108
Published: 14 August 2017
View article titled, Whole-Exome Sequencing of Metaplastic Breast Carcinoma Indicates Monoclonality with Associated Ductal Carcinoma Component
Open the PDF for Whole-Exome Sequencing of Metaplastic Breast Carcinoma Indicates Monoclonality with Associated Ductal Carcinoma Component in another window
Includes: Supplementary data
Journal Articles

Individualized Molecular Analyses Guide Efforts (IMAGE): A Prospective Study of Molecular Profiling of Tissue and Blood in Metastatic Triple-Negative Breast Cancer

Heather A. Parsons, Julia A. Beaver, Ashley Cimino-Mathews, Siraj M. Ali, Jennifer Axilbund, David Chu, Roisin M. Connolly, Rory L. Cochran, Sarah Croessmann, Travis A. Clark, Christopher D. Gocke, Stacie C. Jeter, Mark R. Kennedy, Josh Lauring, Justin Lee, Doron Lipson, Vincent A. Miller, Geoff A. Otto, Gary L. Rosner, Jeffrey S. Ross, Shannon Slater, Philip J. Stephens, Dustin A. VanDenBerg, Antonio C. Wolff, Lauren E. Young, Daniel J. Zabransky, Zhe Zhang, Jane Zorzi, Vered Stearns, Ben H. Park
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (2): 379–386.
https://doi.org/10.1158/1078-0432.CCR-16-1543
Published: 15 January 2017
View article titled, Individualized Molecular Analyses Guide Efforts (IMAGE): A Prospective Study of Molecular Profiling of Tissue and Blood in Metastatic Triple-Negative Breast Cancer
Open the PDF for Individualized Molecular Analyses Guide Efforts (IMAGE): A Prospective Study of Molecular Profiling of Tissue and Blood in Metastatic Triple-Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma

Hsueh-Li Tan, Akshay Sood, Hameed A. Rahimi, Wenle Wang, Nilesh Gupta, Jessica Hicks, Stacy Mosier, Christopher D. Gocke, Jonathan I. Epstein, George J. Netto, Wennuan Liu, William B. Isaacs, Angelo M. De Marzo, Tamara L. Lotan
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (4): 890–903.
https://doi.org/10.1158/1078-0432.CCR-13-1982
Published: 16 February 2014
View article titled, Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma
Open the PDF for Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma in another window
Includes: Supplementary data
Journal Articles

Targeting Vascular Endothelial Growth Factor for Relapsed and Refractory Adult Acute Myelogenous Leukemias: Therapy with Sequential 1-β-d-Arabinofuranosylcytosine, Mitoxantrone, and Bevacizumab

Judith E. Karp, Ivana Gojo, Roberto Pili, Christopher D. Gocke, Jacqueline Greer, Chuanfa Guo, David Qian, Lawrence Morris, Michael Tidwell, Helen Chen, James Zwiebel
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (11): 3577–3585.
https://doi.org/10.1158/1078-0432.CCR-03-0627
Published: 01 June 2004
View article titled, Targeting Vascular Endothelial Growth Factor for Relapsed and Refractory Adult Acute Myelogenous Leukemias: <subtitle>Therapy with Sequential 1-β-<sc>d</sc>-Arabinofuranosylcytosine, Mitoxantrone, and Bevacizumab</subtitle>
Open the PDF for Targeting Vascular Endothelial Growth Factor for Relapsed and Refractory Adult Acute Myelogenous Leukemias: <subtitle>Therapy with Sequential 1-β-<sc>d</sc>-Arabinofuranosylcytosine, Mitoxantrone, and Bevacizumab</subtitle> in another window
Journal Articles

Detection of Tumor Messenger RNA in the Serum of Patients with Malignant Melanoma

Michael S. Kopreski, Floyd A. Benko, Larry W. Kwak, Christopher D. Gocke
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (8): 1961–1965.
Published: 01 August 1999
View article titled, Detection of Tumor Messenger RNA in the Serum of Patients with Malignant Melanoma
Open the PDF for Detection of Tumor Messenger RNA in the Serum of Patients with Malignant Melanoma in another window